📣 VC round data is live. Check it out!
- Public Comps
- Cementos Bio-Bio
Cementos Bio-Bio Valuation Multiples
Discover revenue and EBITDA valuation multiples for Cementos Bio-Bio and similar public comparables like Titan USJE Skopje, Ibstock, Caribbean Cement Company, Marshalls and more.
Cementos Bio-Bio Overview
About Cementos Bio-Bio
Cementos Bio-Bio SA is a cement manufacturing company. The company manufactures and distributes construction materials.
Founded
1957
HQ

Employees
2.9K
Website
Sectors
Financials (FY)
EV
$593M
Valuation Multiples
Start free trialCementos Bio-Bio Financials
Cementos Bio-Bio reported last fiscal year revenue of $408M and EBITDA of $56M.
In the same fiscal year, Cementos Bio-Bio generated $157M in gross profit, $56M in EBITDA, and $36M in net income.
Cementos Bio-Bio P&L
In the most recent fiscal year, Cementos Bio-Bio reported revenue of $408M and EBITDA of $56M.
Cementos Bio-Bio is profitable as of last fiscal year, with gross margin of 39%, EBITDA margin of 14%, and net margin of 9%.
Financial data powered by Morningstar, Inc.
Cementos Bio-Bio Stock Performance
Cementos Bio-Bio has current market cap of $504M, and enterprise value of $593M.
Market Cap Evolution
Cementos Bio-Bio's stock price is $1.91.
Cementos Bio-Bio share price decreased by 0.4% in the last 30 days, and increased by 8.0% in the last year.
Cementos Bio-Bio has an EPS (earnings per share) of $0.14.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $593M | $504M | -1.5% | -0.4% | -2.5% | 8.0% | $0.14 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCementos Bio-Bio Valuation Multiples
Cementos Bio-Bio trades at 1.5x EV/Revenue multiple, and 10.6x EV/EBITDA.
Cementos Bio-Bio Financial Valuation Multiples
As of May 17, 2026, Cementos Bio-Bio has market cap of $504M and EV of $593M.
Cementos Bio-Bio has a P/E ratio of 13.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cementos Bio-Bio Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Cementos Bio-Bio Margins & Growth Rates
In the most recent fiscal year, Cementos Bio-Bio reported gross margin of 39%, EBITDA margin of 14%, and net margin of 9%.
Cementos Bio-Bio Margins
Cementos Bio-Bio Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Cementos Bio-Bio Operational KPIs
Cementos Bio-Bio's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Cementos Bio-Bio Competitors
Cementos Bio-Bio competitors include Titan USJE Skopje, Ibstock, Caribbean Cement Company, Marshalls, Konya Çimento, Eastern Province Cement, Vulcan Steel, PPC, Vassilico Cement Works and Forterra.
Most Cementos Bio-Bio public comparables operate across Building Materials.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 4.3x | — | 10.6x | — | |||
| 1.4x | 1.4x | 7.4x | 7.5x | |||
| 2.3x | — | 7.1x | — | |||
| 0.8x | 0.8x | 6.0x | 5.8x | |||
| 3.2x | — | 19.1x | — | |||
| 1.8x | — | 6.5x | — | |||
| 1.6x | 1.4x | 12.5x | 12.3x | |||
| 1.0x | 0.9x | 6.6x | 5.1x | |||
This data is available for Pro users. Sign up to see all Cementos Bio-Bio competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cementos Bio-Bio
| When was Cementos Bio-Bio founded? | Cementos Bio-Bio was founded in 1957. |
| Where is Cementos Bio-Bio headquartered? | Cementos Bio-Bio is headquartered in Chile. |
| How many employees does Cementos Bio-Bio have? | As of today, Cementos Bio-Bio has over 2K employees. |
| Is Cementos Bio-Bio publicly listed? | Yes, Cementos Bio-Bio is a public company listed on Bolsa de Santiago. |
| What is the stock symbol of Cementos Bio-Bio? | Cementos Bio-Bio trades under CEMENTOS ticker. |
| When did Cementos Bio-Bio go public? | Cementos Bio-Bio went public in 1982. |
| Who are competitors of Cementos Bio-Bio? | Cementos Bio-Bio main competitors include Titan USJE Skopje, Ibstock, Caribbean Cement Company, Marshalls, Konya Çimento, Eastern Province Cement, Vulcan Steel, PPC, Vassilico Cement Works, Forterra. |
| What is the current market cap of Cementos Bio-Bio? | Cementos Bio-Bio's current market cap is $504M. |
| What is the current revenue of Cementos Bio-Bio? | Cementos Bio-Bio's last fiscal year revenue is $408M. |
| What is the current EV/Revenue multiple of Cementos Bio-Bio? | Current revenue multiple of Cementos Bio-Bio is 1.5x. |
| Is Cementos Bio-Bio profitable? | No, Cementos Bio-Bio is not profitable. |
| How many companies Cementos Bio-Bio has acquired to date? | Cementos Bio-Bio hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Cementos Bio-Bio has invested to date? | Cementos Bio-Bio hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Cementos Bio-Bio
Lists including Cementos Bio-Bio
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.